Cargando…
Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics
Huntington’s disease (HD) is a progressive neurodegenerative disease characterized by preferential loss of neurons in the striatum in patients, which leads to motor and cognitive impairments and death that often occurs 10-15 years after the onset of symptoms. The expansion of a glutamine repeat (>...
Autores principales: | Jia, Qingqing, Li, Shihua, Li, Xiao-Jiang, Yin, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815700/ https://www.ncbi.nlm.nih.gov/pubmed/36618375 http://dx.doi.org/10.3389/fimmu.2022.1088124 |
Ejemplares similares
-
Use of large animal models to investigate Huntington's diseases
por: Yan, Sen, et al.
Publicado: (2019) -
Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015) -
Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
por: Jiang, Wenxiao, et al.
Publicado: (2015) -
Multiple pathways contribute to the pathogenesis of Huntington disease
por: Li, Shihua, et al.
Publicado: (2006) -
New pathogenic insights from large animal models of neurodegenerative diseases
por: Yin, Peng, et al.
Publicado: (2022)